Showing results (21-30 of 74) with videos related to
Sort By:
Pageof 8
Journal of Child and Adolescent Psychopharmacology|May 27, 2016
A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity DisorderAnn Childress, Jeffrey Newcorn, Jeffrey G Stark, et al.Current Medical Research and Opinion|September 9, 2022
Symptoms associated with ADHD/treatment-related adverse side effects and their impact on quality of life and work productivity in adults with ADHDJeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, et al.Advances in Therapy|October 11, 2022
Reasons for Treatment Changes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Chart Review StudyJeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, et al.Journal of Child and Adolescent Psychopharmacology|October 18, 2017
Single-Dose Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity DisorderAnn Childress, Shailly Mehrotra, Jogarao Gobburu, et al.Journal of Attention Disorders|October 21, 2016
The Time Course of Effect of Multilayer-Release Methylphenidate Hydrochloride Capsules: A Randomized, Double-Blind Study of Adults With ADHD in a Simulated Adult Workplace EnvironmentSharon B Wigal, Tim Wigal, Ann Childress, et al.Journal of Child and Adolescent Psychopharmacology|September 30, 2005
Efficacy of two long-acting methylphenidate formulations in children with attention- deficit/hyperactivity disorder in a laboratory classroom settingRaul Silva, Rafael Muniz, Linda K Pestreich, et al.Journal of Child and Adolescent Psychopharmacology|July 24, 2018
Relationship Between Symptomatic and Functional Improvement and Remission in a Treatment Response to Stimulant TrialMargaret Weiss, Ann Childress, Greg Mattingly, et al.Biological Psychiatry|July 17, 2007
Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom studyJoseph Biederman, Samuel W Boellner, Ann Childress, et al.Journal of Clinical Psychopharmacology|August 29, 2012
A randomized, double-blind study of 30 versus 20 mg dexmethylphenidate extended-release in children with attention-deficit/hyperactivity disorder: late-day symptom controlMatthew Brams, John Turnbow, Linda Pestreich, et al.Journal of Child and Adolescent Psychopharmacology|February 27, 2025
Viloxazine Extended-Release Administered With Psychostimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Phase 4, Open-Label TrialAnn Childress, Kobby Asubonteng, Georgette Cox, et al.Pageof 8